SI
PFE icon

Sprott Inc’s Pfizer PFE Stock Holding History

Sprott Inc’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-564,976
Closed -$17.4M – 195
2016
Q4 		$17.4M Sell
564,976
-504,181
-47% -$15.4M 1.49% 22
2016
Q3 		$34.4M Sell
1,069,157
-10,540
-1% -$352K 1.22% 12
2016
Q2 		$36.1M Buy
1,079,697
+35,204
+3% +$1.12M 1.86% 10
2016
Q1 		$29.4M Buy
1,044,493
+17,918
+2% +$512K 2.3% 13
2015
Q4 		$31.4M Buy
1,026,575
+8,221
+0.8% +$259K 1.19% 9
2015
Q3 		$30.3M Buy
1,018,354
+125,321
+14% +$4.02M 1.86% 7
2015
Q2 		$28.4M Buy
893,033
+5,059
+0.6% +$165K 2.15% 9
2015
Q1 		$29.3M Buy
887,974
+487,243
+122% +$15.5M 2.33% 7
2014
Q4 		$11.8M Buy
400,731
+2,319
+0.6% +$66.5K 0.88% 27
2014
Q3 		$11.2M Sell
398,412
-426,870
-52% -$12M 0.59% 25
2014
Q2 		$23.2M Buy
825,282
+222,499
+37% +$6.34M 1.44% 17
2014
Q1 		$18.4M Buy
602,783
+114,886
+24% +$3.43M 1.59% 15
2013
Q4 		$14.2M Buy
+487,897
New +$14.2M 1.03% 20

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Sprott Inc's PFE Position: Q1 2017 in Review

Sprott Inc sold out of Pfizer (PFE) in Q1 2017, closing a stake of 564,976 shares — an estimated $17.4M sold.

Sprott Inc first reported a position in PFE in Q4 2013 and held it in 13 quarters. The position peaked at $36.1M in Q2 2016. 2,074 funds tracked by Wall St. Rank hold PFE as of Q1 2017.

  • Sprott Inc reported no remaining Pfizer position as of Q1 2017 after selling out during the quarter.
  • Sprott Inc sold 564,976 Pfizer shares in Q1 2017, an estimated $17.4M.
  • Sprott Inc first reported a position in Pfizer in Q4 2013 and held it in 13 quarters.
  • Sprott Inc's Pfizer position peaked at $36.1M in Q2 2016.
  • 2,074 funds tracked by Wall St. Rank held Pfizer as of Q1 2017.

Based on Sprott Inc's 13F filing for Q1 2017, filed 8 May 2017.